Condensed Consolidated Statements of Cash Flows (Unaudited) - USD ($) $ in Thousands	3 Months Ended		9 Months Ended
	Dec. 31, 2019	Dec. 31, 2018	Dec. 31, 2019	Dec. 31, 2018
Operating activities
Net loss	$ (2,582)	$ (4,048)	$ (7,075)	$ (9,575)
Adjustments to reconcile loss from operations to net cash provided by operating activities
Net restructuring, severance and other charges			40	(268)
Net legal settlements			(15)
Loss on disposal of property & equipment			(5)
Depreciation	854	651	1,774	1,933
Amortization	608	675	1,900	1,892
Amortization of developed technology	3,100	3,400	9,432	9,357
Deferred income taxes			(313)	44
Share-based compensation	1,329	1,282	3,156	2,956
Change in cash surrender value of company owned life insurance policies			11	12
Changes in operating assets and liabilities:			(3,632)	(4,632)
Net cash provided by operating activities			5,273	1,719
Investing activities
Capital expenditures			(3,009)	(1,610)
Capitalized software development costs				(2,189)
Investments in corporate-owned life insurance policies			(26)	(27)
Net cash used in investing activities			(3,035)	(3,826)
Financing activities
Repurchase of common shares to satisfy employee tax withholding			(1,053)	(612)
Principal payments under long-term obligations			(18)	(90)
Net cash used in financing activities			(1,071)	(702)
Effect of exchange rate changes on cash			(33)	(139)
Net increase (decrease) in cash and cash equivalents			1,134	(2,948)
Cash and cash equivalents at beginning of period			40,771	39,943
Cash and cash equivalents at end of period	$ 41,905	$ 36,995	41,905	36,995
SUPPLEMENTAL SCHEDULE OF NON-CASH INVESTING ACTIVITIES:
Accrued capital expenditures			$ 48	$ 31